According to the recent research report titled ‘India Cancer Treatment Market Analysis, 2020’, available with Market Study Report, India cancer treatment market is expected to grow substantially over 2020-2025.
 

The changing eating habits, rising chemical establishments, changes in environment, and food adulteration are the key factors responsible for the continuous increase of cancer cases in India. The excessive consumption of junk food and sedentary lifestyle also contribute to the increasing number of cancer patients. Moreover, the intake of tobacco has been burgeoning in the country, thereby augmenting the total deaths due to tobacco cancer.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2767175/
 

As per the NICPR, the death of one woman in every 8 minutes has been recorded in India on account of cervical cancer. One of out every two women detected with breast cancer dies of it in the country. In 2019, about 0.8 million deaths due to cancer were recorded in India.
 

The rising cognizance among the population and increasing investments in research & development, has led to the surging need for preventive care and on-time diagnosis. In addition, India offers notable opportunities for investors and venture capitalists, as a comparative saturation has been observed in the developed markets.
 

Elaborating on the treatment type, the market is categorized into hormonal therapy, immunotherapy, targeted therapy, chemotherapy, and others. As per the report, the immunotherapy segment witnessed considerable growth during 2015-2019. The growth of this segment is credited to the capability of targeted therapies to destroy only the malignant cells, advanced efficiency, and higher rates of survival associated with their usage. The immunotherapy segment is slated to grow substantially over the forecast timespan due to dearth of medical assistance and surging cases of cancer in India.
 

Moving on to the type, the market is categorized into stomach cancer, lung cancer, non-Hodgkin’s cancer, gynecologic cancer, gastrointestinal cancer, prostate cancer, cervical cancer, colorectal cancer, breast cancer, blood cancer, and others. While speaking of end-user spectrum, India cancer treatment market is divided into cancer & radiation therapy centers, specialty clinics, and hospitals.
 

Major contenders in India cancer treatment market are Johnson and Johnson, F. Hoffmann-La-Roche Ltd., Bristol-Myers Squibb, Celgene Corporation, Astellas Pharma Inc., Bayer AG, Pfizer Inc., Novartis AG, Merck and Co., AstraZeneca Plc, and Amgen among others.